// App-Quantinova.ai

2194 : New oxazaphosphorine prodrugs for immunotherapy and nanomedicine against cancer

Researchers

Presenter

  • Charles Skarbek

Principal Investigators

  • Henri Gonde

  • Melanie Desbois

  • Julia Delahousse

  • Nathalie Chaput-Gras

  • Jean-Pierre Benoit

  • Emilie Roger

  • Angelo Paci

Medical Centers

  • CNRS, Univ. Paris-Sud, Gustave Roussy, Universite Paris-Saclay, Villejuif, France

  • INSERM U , Angers, France

  • INSERM U981, Villejuif, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Breast cancer

  • Lymphomas

  • Sarcoma

  • Solid malignancies

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Ifosfamide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved